Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

WKZO

Published November 17, 2026 · Updated November 18, 2026

Helus psychedelic depression drug succeeds in trial amid safety scrutiny - WKZO

Read the full story at WKZO

psychedelics .” Executives said the company remains on track for ... US to curb China's access to AI chips as Trump heads to Asia . 2h ago · New.

Surfaced by 6 Google Alerts

  • Psychedelics asia
  • Psychedelic press release
  • Psychedelic biotech
  • Magic mushrooms
  • Psychedelic crime
  • Gray market psychedelics